Xiao Lu Selected Research

Mannose-Binding Protein Deficiency

1/2022	Mannan-Binding Lectin Deficiency Limits Inflammation-induced Myeloid-Derived Suppressor Cells Expansion via Modulating Tumor Necrosis Factor Alpha-triggered Apoptosis.
12/2021	Mannan-binding lectin deficiency augments hepatic endoplasmic reticulum stress through IP3R-controlled calcium release.
1/2019	Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway.
1/2019	Mannan-binding lectin attenuates acetaminophen-induced hepatotoxicity by regulating CYP2E1 expression via ROS-dependent JNK/SP1 pathway.
1/2019	Mannan-binding lectin deficiency exacerbates sterile liver injury in mice through enhancing hepatic neutrophil recruitment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Lu Research Topics

Disease

29	Neoplasms (Cancer) 05/2022 - 07/2010
9	Inflammation (Inflammations) 01/2022 - 05/2010
8	Malaria 01/2022 - 05/2015
8	Infections 01/2022 - 10/2009
8	Stroke (Strokes) 01/2022 - 03/2014
7	COVID-19 04/2022 - 01/2020
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 10/2008
6	Carcinogenesis 01/2020 - 07/2010
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2011
5	Mannose-Binding Protein Deficiency 01/2022 - 01/2019
5	Adenocarcinoma of Lung 01/2022 - 07/2010
5	Fibrosis (Cirrhosis) 01/2022 - 01/2016
5	Heart Failure 01/2022 - 07/2018
5	Neoplasm Metastasis (Metastasis) 04/2021 - 07/2010
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2018 - 12/2014
4	Lung Neoplasms (Lung Cancer) 07/2022 - 07/2010
4	Myocardial Infarction 01/2022 - 01/2015
4	Infarction (Infarctions) 01/2022 - 02/2011
4	Hypertension (High Blood Pressure) 01/2021 - 06/2011
4	Hypoxia (Hypoxemia) 10/2020 - 11/2015
3	Necrosis 12/2021 - 01/2016
3	Hepatitis 12/2021 - 01/2013
3	Acute Liver Failure (Fulminant Hepatic Failure) 10/2021 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2011
3	Insulin Resistance 01/2019 - 06/2011
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2014
3	Ischemia 11/2015 - 10/2008
2	monomelic Amyotrophy 02/2022 - 09/2021
2	Ischemic Stroke 01/2022 - 01/2021
2	Arthritis (Polyarthritis) 01/2022 - 12/2021
2	Hypersensitivity (Allergy) 12/2021 - 06/2011
2	Fatty Liver 10/2021 - 01/2016
2	Colonic Neoplasms (Colon Cancer) 12/2020 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 12/2020 - 01/2020
2	Wounds and Injuries (Trauma) 10/2020 - 10/2020
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 05/2020 - 01/2020
2	Ventilator-Associated Pneumonia 05/2020 - 01/2018
2	Hypothermia 02/2020 - 05/2014
2	Melanoma (Melanoma, Malignant) 01/2020 - 05/2019
2	Aphasia (Dysphasia) 01/2020 - 01/2018
2	Cognitive Dysfunction 01/2020 - 02/2011
2	Chemical and Drug Induced Liver Injury 01/2020 - 01/2019
2	Weight Loss (Weight Reduction) 11/2019 - 09/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 12/2017
2	Thrombosis (Thrombus) 05/2017 - 09/2014

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2010
10	Pharmaceutical PreparationsIBA 09/2021 - 07/2011
8	VaccinesIBA 01/2022 - 08/2010
7	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2011
7	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2008
6	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 06/2022 - 01/2017
6	Therapeutic UsesIBA 01/2022 - 07/2011
6	CytokinesIBA 01/2022 - 02/2013
6	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2010
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2018 - 10/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2010
5	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 03/2014
4	Messenger RNA (mRNA)IBA 01/2021 - 02/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2010
3	AerosolsIBA 01/2022 - 01/2018
3	Concanavalin AIBA 12/2021 - 01/2013
3	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2016
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021 - 01/2016
3	Indicators and Reagents (Reagents)IBA 04/2021 - 10/2015
3	Biological ProductsIBA 01/2021 - 10/2015
3	Antiparasitic Agents (Antiparasitics)IBA 01/2021 - 12/2020
3	LipopolysaccharidesIBA 10/2020 - 05/2010
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020 - 05/2018
3	Oxygen (Dioxygen)IBA 10/2020 - 02/2020
3	AntigensIBA 05/2019 - 08/2010
3	Insulin (Novolin)FDA Link 01/2019 - 06/2011
3	Immunoglobulin G (IgG)IBA 01/2017 - 05/2014
2	CalciumIBA 06/2022 - 12/2021
2	Competitive Endogenous RNAIBA 02/2022 - 01/2021
2	Endothelin A ReceptorIBA 01/2022 - 01/2022
2	Gefitinib (Iressa)FDA Link 01/2022 - 07/2021
2	Freund's AdjuvantIBA 01/2022 - 12/2021
2	Phosphotransferases (Kinase)IBA 12/2021 - 01/2020
2	AntibodiesIBA 10/2021 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 07/2012
2	Antimalarials (Antimalarial Agents)IBA 01/2021 - 01/2020
2	Angiotensin IIIBA 01/2021 - 01/2021
2	artemisinin (artemisinine)IBA 01/2021 - 12/2020
2	Small Interfering RNA (siRNA)IBA 12/2020 - 10/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2020 - 05/2018
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020 - 01/2019
2	3' Untranslated Regions (3' UTR)IBA 01/2020 - 11/2019
2	LectinsIBA 01/2019 - 10/2009
2	Complement System Proteins (Complement)IBA 01/2019 - 01/2017
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2018 - 01/2013
2	Serine Proteases (Serine Protease)IBA 12/2017 - 02/2014
2	erucylphosphocholineIBA 06/2017 - 12/2014

Therapy/Procedure

24	Therapeutics 06/2022 - 07/2010
6	Drug Therapy (Chemotherapy) 01/2020 - 03/2012
3	Length of Stay 01/2022 - 05/2020
2	Diskectomy (Discectomy) 02/2022 - 09/2021
2	Subcutaneous Injections 01/2022 - 12/2021
2	Cannula 10/2020 - 05/2020
2	Artificial Respiration (Mechanical Ventilation) 05/2020 - 01/2011
2	Cognitive Training 01/2020 - 01/2018